GLP-1 Vitamins: Nutritional Support & Biomarker Assessment

Last reviewed: May 22, 2026

Last updated: May 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

GLP-1 medications—whether semaglutide, tirzepatide, or other formulations—reduce appetite and food intake, which may lower overall nutrient consumption. Research shows patients on GLP-1 therapy experience reduced caloric intake by 30-40%, making targeted vitamin and mineral supplementation a practical consideration for long-term health.

Unlike generic supplement advice, precision nutrition during GLP-1 therapy requires understanding individual biomarker status and genetic factors affecting nutrient absorption. PlexusDx's approach focuses on data-driven personalization: baseline nutrient screening, genetic predisposition assessment, and provider-guided supplementation protocols tailored to each patient's metabolic profile.

How GLP-1 Medications Alter Nutritional Status

GLP-1 agonists slow gastric emptying and reduce appetite signaling in the brain, leading to lower food volume and variety consumption. This physiological effect means patients absorb fewer calories, macronutrients, and micronutrients—particularly in the first 3-6 months of therapy when appetite suppression is most pronounced.

Studies indicate GLP-1 users may experience deficiencies in vitamin B12, folate, iron, calcium, and vitamin D within 6-12 months if baseline intake is marginal. Regular nutrient monitoring through bloodwork helps identify which vitamins warrant supplementation versus dietary optimization.

Key Vitamins and Minerals to Monitor on GLP-1 Therapy

Not all GLP-1 users require the same supplements; baseline biomarker testing reveals individual deficiency risk. A comprehensive micronutrient panel at therapy initiation and every 6-12 months guides supplementation decisions and prevents unnecessary supplement overload.

Nutrient	Why It Matters on GLP-1	Typical Monitoring Interval
Vitamin B12	Reduced intrinsic factor production; pernicious anemia risk if deficient	Baseline + 12 months
Folate (B9)	Essential for DNA synthesis; low intake increases homocysteine	Baseline + 12 months
Iron	Reduced red meat intake; higher anemia risk in women	Baseline + 6-12 months
Calcium & Vitamin D	GLP-1 slows calcium absorption; osteoporosis risk long-term	Baseline + 12 months
Zinc	Involved in immune function and protein metabolism	Baseline if symptomatic
Magnesium	Electrolyte balance critical; low intake increases cardiac arrhythmia risk	Baseline if symptomatic

Biomarker Testing as the Foundation for Supplementation Strategy

Baseline bloodwork before GLP-1 initiation establishes nutrient baseline status, allowing providers to recommend targeted supplementation rather than empirical multivitamins. Biomarkers such as serum B12, folate, ferritin, 25-OH vitamin D, and magnesium reveal existing deficiency risk and guide intervention timing.

Genetic factors influence how efficiently patients absorb and metabolize certain nutrients. Variations in genes related to B12 absorption (intrinsic factor), iron metabolism (HFE), and vitamin D metabolism (VDR) may predispose some individuals to faster deficiency on appetite-suppressing medications, warranting earlier intervention.

Practical Supplementation Protocol and Provider Oversight

Evidence-based guidelines suggest B12 supplementation (oral or intramuscular) for most GLP-1 users; folate, iron, calcium, and vitamin D supplementation should be individualized based on baseline labs and dietary intake. Avoid high-dose multivitamins that may cause GI upset on reduced food intake—instead, use targeted single or dual nutrient supplements.

Work with your healthcare provider to establish a monitoring schedule: baseline labs before GLP-1 initiation, repeat testing at 6 months if high-risk factors present, and 12-month follow-up for all users. Adjust supplement dosing based on lab results rather than assumptions, and reassess as appetite stabilizes or dietary intake improves.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context on how genetic variants influence nutrient absorption pathways—particularly in genes related to B vitamin metabolism, iron regulation, and vitamin D responsiveness. This information should be interpreted with a qualified healthcare provider to inform supplementation strategy during GLP-1 therapy.

The Precision Peptide Genetic Test reveals predispositions in nutrient metabolism pathways, not exact deficiency outcomes. Variants in genes such as MTHFR (folate metabolism), FTO (metabolic adaptation), and VDR (vitamin D sensitivity) may indicate higher supplementation needs on appetite-suppressing medications, supporting a more personalized conversation with your provider.

Combining baseline biomarker testing with genetic predisposition data creates a comprehensive picture: bloodwork shows current nutrient status, while genetic insights reveal absorption and metabolism tendencies. This dual approach helps your provider recommend supplementation timing, dosage, and form (oral vs. intramuscular) most likely to support your health goals during compounded GLP-1 therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.